797 |
I-LOVE-IT: A Prospective, Multicenter Clinical Trial of TIVOLI Bioabsorbable Polymer Based Sirolimus-Eluting vs. ENDEAVOR Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease: 8-Month Angiographic and 1-Year Clinical Follow-Up Results |
Runlin Gao |
Jul. 21. 09 |
796 |
Comparison of DES versus BMS in Real World Registries |
Gregg W. Stone |
Jul. 21. 09 |
795 |
DES Pathobiology: Insights from Assessment of Endothelial Integrity and Function |
Renu Virmani |
Jul. 21. 09 |
794 |
The Clinical Spectrum of DES Thrombosis: Multifactorial Causes, Clinical Presentations, and Recommended Treatment Strategies |
Ron Waksman |
Jul. 21. 09 |
793 |
CEA vs. CAS, Which Will Be Consensus in Symptomatic Carotid Stenosis ? |
John R. Laird |
Jul. 21. 09 |
792 |
Future DES: What¡¯s New and Innovative in Drugs, Carrier Vehicles, and Stent Platforms |
Alexandre Abizaid |
Jul. 21. 09 |
791 |
The Changing Landscape of DES Use Patterns: Finally Stabilizing or Still in Transition? |
Martin Bert Leon |
Jul. 21. 09 |
790 |
CABG Remains an Excellent Selection for All Patients ! |
David Paul Taggart |
Jul. 21. 09 |
789 |
Time to Move into Stenting in All Patients ! |
Patrick W. Serruys |
Jul. 21. 09 |
788 |
Fully Integrated Invasive Imaging Solutions: Online Networking of Angiography, IVUS, FFR, OCT, ICE, VP Imaging, Etc |
Gary S. Mintz |
Jul. 21. 09 |